[The use of melatonin continues to increase - rational prescribing and follow-up is important].

Abstract

The prescribing of melatonin continues to increase and occurs partially off-label. The largest increase is among children aged 6-17 years. During the COVID pandemic, the over-the-counter sales of melatonin increased despite jet lag in adults being the only approved indication. The Swedish Medical Products Agency notes an increased interest in melatonin and signals of unwarranted sale of melatonin as a dietary supplement. There is a risk that melatonin medications are used too casually. In addition, knowledge of the long-term effects of melatonin use is scarce. The increasing use of melatonin needs to be highlighted and monitored to ensure rational use.